Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-1995 | 10-1994 | 10-1993 | 10-1992 | 10-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,458 | 4,018 | 2,376 | 582 | 2,981 |
| Depreciation Amortization | 3,520 | 3,083 | 2,059 | 1,825 | 1,779 |
| Other Working Capital | -8,501 | -7,113 | -10,385 | 2,511 | 3,741 |
| Other Operating Activity | 385 | -1,763 | -273 | -332 | -427 |
| Operating Cash Flow | $3,862 | $-1,775 | $-6,223 | $4,586 | $8,074 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,047 | -6,285 | -2,660 | -2,430 | -989 |
| Net Acquisitions | 0 | -1,571 | -2,608 | N/A | N/A |
| Other Investing Activity | 8,246 | -1,013 | -4,016 | 881 | -4,890 |
| Investing Cash Flow | $-7,801 | $-8,869 | $-9,284 | $-1,549 | $-5,879 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 3,776 | 11,932 | 14,510 | -4,053 | -3,082 |
| Financing Cash Flow | $3,776 | $11,932 | $14,510 | $-4,053 | $-3,082 |
| Beginning Cash Position | 2,188 | 900 | 1,897 | 2,913 | 3,800 |
| End Cash Position | 2,025 | 2,188 | 900 | 1,897 | 2,913 |
| Net Cash Flow | $-163 | $1,288 | $-997 | $-1,016 | $-887 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,862 | -1,775 | -6,223 | 4,586 | 8,074 |
| Free Cash Flow | 3,862 | -1,775 | -6,223 | 4,586 | 8,074 |